While direct studies on At4g02650 are absent in the provided sources, its antibody likely supports techniques such as:
Western blotting: Detecting protein expression levels under experimental conditions .
Immunohistochemistry: Localizing the protein in plant tissues .
Functional genomics: Validating CRISPR/Cas9 knockout lines .
Tissue cross-reactivity (TCR) studies are critical for monoclonal antibodies to ensure specificity . For At4g02650, such studies would involve:
Screening against 37 human tissues (standard for TCR assays) .
Testing at three antibody concentrations to assess off-target binding .
No validation data for this specific antibody is provided, but standard protocols recommend including controls like:
The At4g02650 antibody belongs to a broader catalog of Arabidopsis antibodies targeting proteins such as BRN2, BOR1, and CYP714A2 . These share similar applications but differ in target specificity:
| Antibody | Target Function | Uniprot ID |
|---|---|---|
| At4g02650 Antibody | Undefined (hypothetical protein) | Q8GX47 |
| CYP714A2 Antibody | Cytochrome P450 enzyme | Q6NKZ8 |
| BOR1 Antibody | Boron transporter | Q8VYR7 |
Knowledge gaps: The functional role of At4g02650 remains uncharacterized in public databases.
Opportunities: CRISPR-based knockout studies paired with this antibody could elucidate its biological significance.
At4g02650 (UniProt Number: Q8GX47) is a gene in Arabidopsis thaliana with the Entrez Gene ID 828212. While the complete biological function has not been fully characterized in the provided search results, it appears to be expressed during female gametophyte development in Arabidopsis. The gene product likely plays a role in reproductive development, as indicated by transcriptome analysis studies of the Arabidopsis female gametophyte . Researchers investigating this protein should consider its potential involvement in plant reproduction and development pathways when designing experiments.
The commercially available At4g02650 antibody is a rabbit polyclonal antibody purified by Antigen Affinity techniques. The antibody is raised against recombinant Arabidopsis thaliana At4g02650 protein as the immunogen. The commercial preparation typically includes three components: 200μg antigens (used as positive control), 1ml pre-immune serum (used as negative control), and the rabbit polyclonal antibodies themselves . The antibody has been validated for ELISA and Western Blot (WB) applications and demonstrates reactivity with plant species .
| Specification | Details |
|---|---|
| Clone Type | Polyclonal |
| Source/Host | Rabbit |
| Purification Method | Antigen Affinity |
| Immunogen | Recombinant Arabidopsis thaliana At4g02650 protein |
| Validated Applications | ELISA, Western Blot |
| Species Reactivity | Plant |
| Isotype | IgG |
| Recommended Storage | -20°C or -80°C |
For rigorous validation of At4g02650 antibody specificity, implement a multi-step approach. First, perform Western blot analysis using both the supplied positive control antigen (200μg) and the negative control pre-immune serum (1ml) that typically accompanies the antibody . Second, include appropriate biological controls in your experiments - ideally wild-type Arabidopsis tissue alongside At4g02650 knockout or knockdown lines if available.
For advanced validation, consider using transcriptome data from female gametophyte studies to identify tissues with differential At4g02650 expression levels . Comparing antibody reactivity between tissues with high and low expression provides additional evidence of specificity. When testing in plants other than Arabidopsis, perform preliminary cross-reactivity tests against protein extracts from multiple plant species at varying antibody dilutions to determine optimal conditions.
For optimal Western blot results with At4g02650 antibody, consider the following methodological approach based on general antibody practices and the specific characteristics of this antibody:
Sample preparation: Extract total protein from Arabidopsis tissues using a plant-specific extraction buffer containing protease inhibitors to prevent degradation. Based on gene expression data, female reproductive tissues may show higher expression levels .
Gel electrophoresis: Separate 20-50μg of total protein on an SDS-PAGE gel (10-12% is typically suitable for most plant proteins).
Transfer conditions: Transfer to a PVDF membrane at 100V for 60-90 minutes in standard transfer buffer.
Blocking: Block the membrane with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature.
Primary antibody incubation: Dilute the At4g02650 antibody (start with 1:1000 and optimize as needed) in blocking buffer and incubate overnight at 4°C.
Washing and secondary antibody: Wash with TBST and incubate with HRP-conjugated anti-rabbit secondary antibody (typically 1:5000 dilution) for 1 hour at room temperature.
Detection: Develop using an enhanced chemiluminescence (ECL) system.
Always include the positive control antigen provided with the antibody to confirm detection functionality .
For immunolocalization of At4g02650 in plant tissues, consider this methodological approach:
Tissue fixation: Fix freshly harvested Arabidopsis tissues (preferably including female reproductive structures based on expression data ) in 4% paraformaldehyde for 2-4 hours at room temperature.
Tissue processing: Dehydrate tissues through an ethanol series, clear with xylene, and embed in paraffin. Section tissues at 5-10μm thickness.
Antigen retrieval: After deparaffinization, perform antigen retrieval using citrate buffer (pH 6.0) at 95°C for 10-20 minutes to expose epitopes that may have been masked during fixation.
Blocking: Block with 2-5% BSA or normal goat serum in PBS with 0.1% Triton X-100 for 1 hour at room temperature.
Primary antibody incubation: Dilute At4g02650 antibody (1:100 to 1:500, optimize as needed) in blocking solution and incubate sections overnight at 4°C.
Secondary antibody: After washing, incubate with fluorophore-conjugated anti-rabbit secondary antibody (1:200 to 1:500) for 1-2 hours at room temperature.
Counterstaining: Counterstain nuclei with DAPI (1μg/ml) for 5 minutes.
Controls: Include negative controls using pre-immune serum and positive controls using tissues known to express At4g02650 based on transcriptome data .
Analysis: Image using confocal microscopy with appropriate filter sets for your fluorophore.
To investigate protein-protein interactions involving At4g02650, consider these methodological strategies:
Co-immunoprecipitation (Co-IP):
Prepare protein extracts from Arabidopsis tissues expressing At4g02650
Immobilize the At4g02650 antibody on protein A/G beads
Incubate with protein extracts to capture At4g02650 and its interacting partners
Wash extensively to remove non-specific interactions
Elute bound proteins and analyze by mass spectrometry
Proximity-dependent biotin identification (BioID):
Generate transgenic plants expressing At4g02650 fused to a biotin ligase (BirA*)
The BirA* will biotinylate proteins in close proximity to At4g02650 in vivo
Purify biotinylated proteins using streptavidin beads
Identify interacting proteins by mass spectrometry
Yeast two-hybrid screening:
Clone At4g02650 as bait in a yeast two-hybrid system
Screen against an Arabidopsis cDNA library
Validate positive interactions through secondary screens
These approaches can be particularly valuable for understanding the molecular function of At4g02650, especially given its potential role in female gametophyte development as suggested by transcriptome data .
While comprehensive developmental expression data specifically for At4g02650 is limited in the provided search results, we can infer from the transcriptome analysis of female gametophytes that At4g02650 shows expression during reproductive development . The analysis of female gametophyte transcriptome in Arabidopsis compared heterozygous ovules (containing embryo sacs) with sporocyteless (spl) mutant ovules (lacking embryo sacs).
For researchers interested in At4g02650 expression patterns, it would be valuable to consult publicly available Arabidopsis expression databases like AtGenExpress or BAR eFP Browser, which provide tissue-specific and developmental stage-specific expression data across multiple experimental conditions. Additionally, researchers should consider performing RT-qPCR analysis across different tissues and developmental stages to generate a comprehensive expression profile for this gene before embarking on protein-level studies with the antibody.
To establish correlations between At4g02650 transcription and protein abundance:
Paired analysis approach:
Collect Arabidopsis tissues from multiple developmental stages or treatment conditions
Split each sample into two portions
Extract RNA from one portion for RT-qPCR or RNA-seq analysis of At4g02650 transcript levels
Extract protein from the other portion for Western blot quantification using the At4g02650 antibody
Calculate correlation coefficients between transcript and protein levels
Time-course studies:
Induce expression changes through developmental progression or environmental stimuli
Collect samples at regular intervals
Analyze both transcript and protein dynamics
Determine the temporal relationship between changes in transcript and protein levels
Single-cell approaches:
Include appropriate internal controls for both transcript analysis (reference genes) and protein quantification (loading controls) to ensure reliable correlations.
When working with At4g02650 antibody, researchers may encounter several challenges:
High background in Western blots:
Increase blocking time or blocking agent concentration (5-10% milk/BSA)
Increase washing duration and frequency (5 washes × 5 minutes with TBST)
Optimize primary antibody dilution (try 1:1000 to 1:5000 range)
Include 0.1-0.5% Tween-20 in antibody dilution buffer
Weak or no signal:
Multiple bands or non-specific binding:
Poor reproducibility:
Standardize protein extraction protocols
Aliquot antibody upon receipt to avoid freeze-thaw cycles
Document lot-to-lot variations of the antibody
Maintain consistent incubation times and temperatures
For optimal immunoprecipitation results with At4g02650 antibody:
Buffer optimization:
Test different lysis buffers (RIPA, NP-40, or plant-specific buffers)
Include protease inhibitors and phosphatase inhibitors if studying phosphorylation
Adjust salt concentration (150-500mM NaCl) to reduce non-specific binding
Antibody binding:
Determine optimal antibody-to-protein ratio (typically 2-5μg antibody per 500μg-1mg protein extract)
Compare direct antibody addition versus pre-binding to protein A/G beads
Consider cross-linking the antibody to beads to prevent co-elution
Washing conditions:
Implement a stepwise washing strategy with decreasing detergent/salt concentrations
Optimize number of washes (typically 4-6) to balance removal of non-specific binding with retention of specific interactions
Elution methods:
Compare different elution conditions (low pH, high pH, SDS, or peptide competition)
For mass spectrometry applications, consider on-bead digestion to minimize contaminants
Controls:
Recent advances in CRISPR-based gene tagging offer powerful approaches for studying At4g02650 function when combined with antibody-based detection:
Endogenous tagging strategy:
Use CRISPR/Cas9 to insert epitope tags (HA, FLAG, GFP) at the C-terminus of endogenous At4g02650
Compare protein localization and expression using both the At4g02650 antibody and tag-specific antibodies
This cross-validation approach enhances confidence in antibody specificity
GAL4-UAS reporter system integration:
Combinatorial approaches:
Generate knock-in reporter lines for live imaging
Use the At4g02650 antibody for biochemical validation
This multi-modal approach provides complementary data on protein dynamics
These CRISPR-based approaches can significantly enhance studies of At4g02650 function, particularly in specialized tissues like the female gametophyte where expression has been detected .
Advanced protein design methodologies, such as those using diffusion probabilistic models, could potentially be applied to improve At4g02650 antibody specificity:
Epitope optimization:
Complementarity-determining region (CDR) enhancement:
Side-chain optimization:
While these technologies are emerging and currently more developed for therapeutic antibodies , their application to research antibodies like At4g02650 represents an exciting frontier for improving research tools in plant biology.